CD37 in B Cell Derived Tumors—More than Just a Docking Point for Monoclonal Antibodies

CD37 is a tetraspanin expressed prominently on the surface of B cells. It is an attractive molecular target exploited in the immunotherapy of B cell-derived lymphomas and leukemia. Currently, several monoclonal antibodies targeting CD37 as well as chimeric antigen receptor-based immunotherapies are...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobrowicz, Malgorzata, Kubacz, Matylda, Slusarczyk, Aleksander, Winiarska, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765243/
https://www.ncbi.nlm.nih.gov/pubmed/33333768
http://dx.doi.org/10.3390/ijms21249531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765243/
https://www.ncbi.nlm.nih.gov/pubmed/33333768
http://dx.doi.org/10.3390/ijms21249531

Ejemplares similares